
Results
25
Most Popular Stocks on the market
25 companies
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.
CLN
zł21.10
7D
7.1%
1Y
-12.1%
Selvita
Market Cap: zł550.7m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł29.60
7D
-2.0%
1Y
-6.9%
Bioceltix
Market Cap: zł517.3m
Engages in the development of veterinary biologics based on mesenchymal stem cells.
BCX
zł92.60
7D
2.0%
1Y
-11.8%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł475.9m
A biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.
CTX
zł75.30
7D
-0.1%
1Y
82.3%
Ryvu Therapeutics
Market Cap: zł346.3m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł14.90
7D
-2.7%
1Y
-52.8%
BIOTON
Market Cap: zł329.3m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł3.82
7D
-0.4%
1Y
-8.3%
Synthaverse
Market Cap: zł206.1m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł2.75
7D
0%
1Y
-46.1%
Mabion
Market Cap: zł123.2m
A biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.
MAB
zł7.86
7D
6.5%
1Y
-17.3%
Molecure
Market Cap: zł120.3m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.80
7D
-2.0%
1Y
1.0%
Poltreg
Market Cap: zł116.6m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.60
7D
2.3%
1Y
-38.4%
NanoGroup
Market Cap: zł107.2m
Operates as a biotechnology company in Poland.
NNG
zł2.51
7D
0.4%
1Y
-4.7%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-34.6%
Urteste
Market Cap: zł73.3m
Engages in the research and development of diagnostic tests for cancers.
URT
zł47.00
7D
-2.5%
1Y
-4.3%
Genomtec
Market Cap: zł70.7m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł4.63
7D
-1.5%
1Y
-27.5%
Read-Gene
Market Cap: zł56.8m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł4.60
7D
-1.1%
1Y
-11.5%
Biogened
Market Cap: zł45.2m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł18.50
7D
0%
1Y
-32.5%
Genomed Spólka Akcyjna
Market Cap: zł35.9m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł27.60
7D
-5.5%
1Y
7.0%
Medicofarma Biotech
Market Cap: zł28.0m
Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
MDB
zł0.41
7D
-1.9%
1Y
34.6%
Pure Biologics
Market Cap: zł26.4m
A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.
PUR
zł2.11
7D
-1.9%
1Y
-65.4%
genXone
Market Cap: zł19.0m
Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.
GX1
zł5.74
7D
-4.7%
1Y
-0.7%
Stem Cells Spin
Market Cap: zł16.9m
Operates as a biotechnology company in Poland.
SCS
zł0.50
7D
33.7%
1Y
89.4%
Green Zebras Spolka Akcyjna
Market Cap: zł14.9m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.50
7D
4.4%
1Y
8.0%
Cannabis Poland
Market Cap: zł13.4m
Operates in the medical cannabis industry in Poland.
CBD
zł0.18
7D
-2.7%
1Y
-47.0%
Tecnovatica
Market Cap: zł5.7m
Does not have significant operations.
TEC
zł0.53
7D
3.5%
1Y
26.9%
Labocanna
Market Cap: zł4.6m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.22
7D
-1.4%
1Y
-30.3%